Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
"BSP1" is a non-specific designation that refers to several distinct biological entities with diverse functions and potential applications. These include: 1. **Black Soybean Peptide 1 (BSP1)**: A peptide derived from black soybeans, investigated for its neuroprotective effects against lead-induced neurotoxicity and Alzheimer's-related neuroinflammation. It acts by enhancing antioxidant activity and modulating key signaling pathways like RhoA/MAPK and AMPK/SIRT1. 2. **Bletilla striata Polysaccharide 1 (BSP1-1 or BSP1)**: A homogeneous polysaccharide extracted from the traditional Chinese medicinal herb *Bletilla striata*. It has shown promise in promoting wound healing in diabetic rats by reducing oxidative stress and enhancing angiogenesis and collagen deposition. It also plays a role in alleviating cadmium toxicity. 3. **Binder of Sperm Protein 1 (BSP1)**: A protein found in the seminal plasma of various mammals (e.g., bulls, rams, boars). It is crucial for sperm function, including motility, capacitation, and interaction with oocytes, and is considered a biomarker for male fertility. 4. **Bacillus subtilis strain BSP1**: A bacterial strain isolated from tobacco leaves, known for its ability to degrade proteins, which is relevant for improving tobacco leaf quality. 5. **Bone Sialoprotein 1 (BSP1)**: A gene/protein that serves as a marker for osteogenic differentiation, relevant in studies of bone regeneration and tissue engineering. 6. **Bsp1 (fungal CPI motif protein)**: A fungal protein identified in budding yeast, which regulates actin filament capping, a fundamental process in endocytosis and cytokinesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BSP1.